pyridoxine has been researched along with Disease Exacerbation in 11 studies
4,5-bis(hydroxymethyl)-2-methylpyridin-3-ol: structure in first source
vitamin B6 : Any member of the group of pyridines that exhibit biological activity against vitamin B6 deficiency. Vitamin B6 deficiency is associated with microcytic anemia, electroencephalographic abnormalities, dermatitis with cheilosis (scaling on the lips and cracks at the corners of the mouth) and glossitis (swollen tongue), depression and confusion, and weakened immune function. Vitamin B6 consists of the vitamers pyridoxine, pyridoxal, and pyridoxamine and their respective 5'-phosphate esters (and includes their corresponding ionized and salt forms).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pyridoxine-dependent epilepsy (PDE) is a cause of neonatal epileptic encephalopathy not previously known to cause ophthalmic disease." | 7.79 | Congenital cataract in a child with pyridoxine-dependent epilepsy. ( Hildebrand, GD; Sandford, V; Yusuf, IH, 2013) |
| "Gyrate atrophy is a rare autosomal recessive disorder caused by a mutation in the ornithine-δ-amino transferase gene." | 3.88 | Unique case of gyrate atrophy with a well-preserved electroretinogram (ERG). ( Black, G; Jasani, KM; Kelly, SP; Parry, NRA, 2018) |
| "Pyridoxine-dependent epilepsy (PDE) is a cause of neonatal epileptic encephalopathy not previously known to cause ophthalmic disease." | 3.79 | Congenital cataract in a child with pyridoxine-dependent epilepsy. ( Hildebrand, GD; Sandford, V; Yusuf, IH, 2013) |
| "Primary hyperoxalurias are rare recessive inherited inborn errors of glyoxylate metabolism." | 1.37 | [Primary hyperoxaluria]. ( Bacchetta, J; Bertholet-Thomas, A; Cochat, P; Fargue, S; Harambat, J; Sabot, JF, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 4 (36.36) | 29.6817 |
| 2010's | 6 (54.55) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jasani, KM | 1 |
| Parry, NRA | 1 |
| Black, G | 1 |
| Kelly, SP | 1 |
| Vidaurre, J | 1 |
| Nunley, S | 1 |
| Yusuf, IH | 1 |
| Sandford, V | 1 |
| Hildebrand, GD | 1 |
| Mayengbam, S | 1 |
| Raposo, S | 1 |
| Aliani, M | 1 |
| House, JD | 1 |
| Padmavathy, L | 1 |
| Rao, LL | 1 |
| Ethirajan, N | 1 |
| Dhanlaklshmi, M | 1 |
| Richard, E | 1 |
| Kuiper, R | 1 |
| Dijkgraaf, MG | 1 |
| Van Gool, WA | 1 |
| Cochat, P | 1 |
| Fargue, S | 1 |
| Bacchetta, J | 1 |
| Bertholet-Thomas, A | 1 |
| Sabot, JF | 1 |
| Harambat, J | 1 |
| Dogan, M | 1 |
| Dogan, DG | 1 |
| Kahraman, AS | 1 |
| Ozcan, O | 1 |
| Yakinci, C | 1 |
| Alkan, A | 1 |
| Stapley, PJ | 1 |
| Ting, LH | 1 |
| Hulliger, M | 1 |
| Macpherson, JM | 1 |
| Perry, TA | 1 |
| Weerasuriya, A | 1 |
| Mouton, PR | 1 |
| Holloway, HW | 1 |
| Greig, NH | 1 |
| Tang, AM | 1 |
| Graham, NM | 1 |
| Chandra, RK | 1 |
| Saah, AJ | 1 |
1 trial available for pyridoxine and Disease Exacerbation
| Article | Year |
|---|---|
Vascular care in patients with Alzheimer's disease with cerebrovascular lesions-a randomized clinical trial.
Topics: Activities of Daily Living; Aged; Alzheimer Disease; Aspirin; Cerebrovascular Disorders; Cost-Benefi | 2009 |
10 other studies available for pyridoxine and Disease Exacerbation
| Article | Year |
|---|---|
Unique case of gyrate atrophy with a well-preserved electroretinogram (ERG).
Topics: Adult; Cataract; Cataract Extraction; Diet, Protein-Restricted; Disease Progression; Electroretinogr | 2018 |
Atypical Presentation of a Progressive and Treatable Encephalopathy in an Older Child With Gelastic and Dacrystic Seizures.
Topics: Adolescent; Anticonvulsants; Brain; Diagnosis, Differential; Disease Progression; Epilepsies, Partia | 2018 |
Congenital cataract in a child with pyridoxine-dependent epilepsy.
Topics: Aldehyde Dehydrogenase; Cataract; Child, Preschool; Disease Progression; Epilepsy; Female; Humans; M | 2013 |
Oral exposure to the anti-pyridoxine compound 1-amino D-proline further perturbs homocysteine metabolism through the transsulfuration pathway in moderately vitamin B₆ deficient rats.
Topics: Animals; Asymptomatic Diseases; Biomarkers; Cystathionine; Cystathionine gamma-Lyase; Diet; Disease | 2015 |
Psoriasiform lupus vulgaris.
Topics: Adolescent; Antitubercular Agents; Biopsy; Buttocks; Child; Disease Progression; Ethambutol; Female; | 2008 |
[Primary hyperoxaluria].
Topics: Alanine Transaminase; Disease Progression; Genotype; Humans; Hyperoxaluria; Hyperoxaluria, Primary; | 2011 |
A 9-year follow-up of a girl with pyridoxine (vitamin B6)-dependent seizures: magnetic resonance spectroscopy findings.
Topics: Adolescent; Anticonvulsants; Aspartic Acid; Biomarkers; Brain; Child; Creatinine; Disease Progressio | 2012 |
Automatic postural responses are delayed by pyridoxine-induced somatosensory loss.
Topics: Afferent Pathways; Animals; Ataxia; Behavior, Animal; Cats; Disease Progression; Electromyography; F | 2002 |
Pyridoxine-induced toxicity in rats: a stereological quantification of the sensory neuropathy.
Topics: Animals; Cell Count; Cell Size; Disease Models, Animal; Disease Progression; Electrophysiology; Gang | 2004 |
Low serum vitamin B-12 concentrations are associated with faster human immunodeficiency virus type 1 (HIV-1) disease progression.
Topics: Adult; Age Factors; Aged; Alcohol Drinking; Bisexuality; Body Mass Index; C-Reactive Protein; CD4 Ly | 1997 |